SIGN IN
|
SIGN UP
ISSN 0973 - 9289
HOME
(current)
TOPICS
ASK A DOCTOR
GRAND ROUNDS
Question of the week
BLOGS
SUBMIT
CONFERENCE
VIDEOS
HIV CONFERENCES
International Conference on HIV/AIDS (IC-HA) - ITAR
Venue:
Dallas, USA
Conference Date:
01/10/2025 - 01/10/2025
International Conference on Auditory Rehabilitation and Hearing Aids Technology (ICARHAT) - ISAR
Venue:
Las vegas, USA
Conference Date:
01/28/2025 - 01/28/2025
International Conference on HIV, AIDS and Sexually Transmitted Infections (ICHASTI) - Research Fora
Venue:
New York, USA
Conference Date:
01/31/2025 - 01/31/2025
International Conference on HIV and AIDS (ICHIVA) - Science Cite
Venue:
Chicago, USA
Conference Date:
01/31/2025 - 01/31/2025
International Conference on Auditory Rehabilitation and Hearing Aids Technology (ICARHAT)
Venue:
Los Angeles, USA
Conference Date:
01/31/2025 - 01/31/2025
International Conference on Audiology and Hearing Aids (ICAAHA) - ISAR
Venue:
Boston, USA
Conference Date:
01/31/2025 - 01/31/2025
International Conference on HIV/AIDS Prevention and Treatment (ICHAPT) - ISIT
Venue:
Las vegas, USA
Conference Date:
01/31/2025 - 01/31/2025
International Conference on HIV, AIDS and Sexually Transmitted Infections (ICHASTI) - IIRST
Venue:
New York, USA
Conference Date:
02/14/2025 - 02/14/2025
International Conference on HIV, AIDS and Sexually Transmitted Infections (ICHASTI) - IIRST
Venue:
Denver, USA
Conference Date:
02/14/2025 - 02/14/2025
International Conference on HIV/AIDS Prevention and Treatment (ICHAPT) - SCIENCENET
Venue:
San Francisco, USA
Conference Date:
02/14/2025 - 02/14/2025
International Conference on Audiology and Hearing Aids (ICAAHA) - ITAR
Venue:
Las vegas, USA
Conference Date:
02/14/2025 - 02/14/2025
International Conference on Auditory Rehabilitation and Hearing Aids Technology (ICARHAT) - IITER
Venue:
Austin, USA
Conference Date:
02/14/2025 - 02/14/2025
International Conference on HIV and AIDS (ICHIVA) - IIERD
Venue:
California, USA
Conference Date:
02/14/2025 - 02/14/2025
HIV GRAND ROUNDS
A 32 years old HIV infected pregnant female (G2P2L1) presented at 36 weeks of pregnancy for deciding neonatal antiretroviral (ARV) prophylaxis. Her HIV viral load at 34 weeks of gestation was undetectable and she was on antiretroviral therapy (ART) consisting ....
HIV IN CHILDREN APPS